REPH
Recro Pharma Inc
Price:  
2.09 
USD
Volume:  
142,593.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPH Stock Forecast & Price Target

REPH Stock Price Forecast

The average stock forecast for Recro Pharma Inc (REPH) in the next 12 months is 5.10 USD. This price target corresponds to an upside of 144.02%. The range of stock forecasts for REPH is 4.04 - 6.30 USD. Based on the ratings of 0 analysts, the consensus recommendation for REPH is HOLD.
Target Low Average Median High
Price (USD) 4.04 5.10 5.10 6.30
Upside 93.30% 144.02% 144.02% 201.44%

Recommendation Trends

The latest consensus rating for REPH is "HOLD". This is the average recommendation of 0 analysts: strong sell, sell, hold, buy, strong buy. In the previous period, 0 analysts also majorly recommmended "HOLD" for REPH.

REPH Financial Stock Forecast

Revenue This Year
71.58M
-5.01%
from 75.36M
Revenue Next Year
69.81M
-2.48%
from 71.58M
EPS This Year
-0.97
302.27%
from -0.24
EPS Next Year
-0.36
-63.49%
from -0.97